USFDA completes inspection at Natco Pharma’s API facility in Chennai

15 Jul 2019 Evaluate

US Food and Drug Administration (USFDA) has completed inspection at Natco Pharma’s Active Pharmaceutical Ingredient (API) facility in Chennai in the state of Tamil Nadu. The inspection was conducted from July 8 to July 12, 2019. The regulatory audit resulted in zero observations.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

888.60 -14.95 (-1.65%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×